Neo-Sinefrina Alergo (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Neo‑Sinefrina Alergo, is a corticosteroid presented as a nasal spray for intranasal use. It is indicated for the treatment of allergic rhinitis, helping to reduce nasal inflammation, congestion and itching in adults and children. GNH USA supplies Neo‑Sinefrina Alergo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neo‑Sinefrina Alergo is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: relieves nasal congestion, sneezing and itching caused by seasonal or perennial allergens. - Seasonal allergic rhinitis: reduces symptom severity during pollen seasons. - Perennial allergic rhinitis: provides ongoing control of year‑round nasal inflammation.

Adverse reactions may occur with intranasal use of beclometasone dipropionate.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Epistaxis (nosebleeds) - Headache - Altered taste or bitter taste - Throat irritation or cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes such as cataracts or glaucoma - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal passages

Use Neo‑Sinefrina Alergo only as prescribed and limit duration to the shortest effective period. - Avoid prolonged continuous use: monitor for signs of local irritation or systemic effects. - Monitor patients with glaucoma or cataract risk: intra‑ocular pressure may increase. - Caution in diabetic patients: systemic absorption can affect glucose control. - Do not use if you have a known hypersensitivity to beclometasone or any excipients. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Beclometasone dipropionate may interact with other medications that affect corticosteroid metabolism or immune response.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local steroid exposure. - Antifungal agents that inhibit steroid metabolism.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedative effects when combined with first‑generation agents. - Decongestant nasal sprays: concurrent use may increase local irritation. - Immunosuppressants: monitor for heightened infection risk.